Search Results 1131-1140 of 17012 for pharmacogenetics
Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment- ...
The purpose of this study is to use HOUsing-based SocioEconomic Status (HOUSES) index, an innovative housing-based, individual-level SES measure and social ...
To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...
The purpose of this study is to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future testing of potential ...
The purpose of this study is to evaluate participants for immune responses and histological changes in the small bowel following 2 doses of TIMP-GLIA or placebo ...
The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...
Hennessy MA, Gatsonis C, Jacene H, Connolly RM, Burnette BL, Stringer-Reasor EM, Romanoff J, Taurone A, O'Sullivan CC, Le-Petross HT, Stearns V, Fowler AM, ...
Latest stories · Innovative Mayo Clinic test may improve mesothelioma detection rate in blood featured image · Baby Oliver leaves legacy of genomic advances at ...
Safety and efficacy study of SANGUINATE on reduction of delayed graft function (DGF) in patients who will be recipients of a donation after brain death (DBD) ...
Proton therapy may be better option for elderly patients with esophageal cancer featured image · Science Saturday: Developing a digital bloodhound featured image.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.